Report me for selling fake medicine? Why are you crying when your illness relapses?

……

"Well, that's fine!"

"Then let's meet. I'll have time in a few days."

"If AbbVie representatives are interested, please contact me at this time."

After hesitating for a while, Chen Xuan made a decision directly.

Anyway, meeting each other won’t waste much time. At most, you will just have to do fewer experiments.

Just think of it as giving yourself half a day off, it won’t affect your other work.

Chen Xuan naturally knew exactly what these pharmaceutical companies were thinking.

These pharmaceutical companies know better than he does how valuable the lung cancer drug is.

The most important thing is that judging from the current performance, the chances of this special medicine being successfully launched on the market are very high.

If you want to get a specific drug for lung cancer, now is the best time and you can get it at the lowest price.

Once the clinical trials are completed, the formula for the lung cancer drug will become extremely expensive.

There is a world of difference between whether clinical trials are completed or not, and the value of the formula will also vary greatly depending on the results.

After all, before clinical trials, this type of drug has a certain risk of failure. Considering this risk, the valuation will naturally be much lower.

But once all risks are eliminated, the product successfully passes clinical trials and is approved for marketing, it will not be able to be obtained at the original price, and it is estimated to increase several times.

A formula that was originally worth only 10 billion yuan may directly increase to 30 to 50 billion yuan after passing clinical trials.

The high investment in clinical trials is one thing, but more importantly, many drugs are declared failures during clinical trials.

Therefore, whether or not a product has passed clinical trials will become a dividing line, and the value will also be very different.

The current performance of lung cancer specific drugs only shows that the chances of passing clinical trials are slightly higher, but it does not mean that they will definitely pass.

However, the market potential of lung cancer-specific drugs is so great that these pharmaceutical companies are willing to take the risk of acquiring them.

As a result, now is the best time to get a specific drug for lung cancer.

The closer to the end, the higher the value, and the rate of return is not so ideal.

Therefore, Chen Xuan knew that in the future, various acquisition plans would emerge one after another.

But he also figured it out. Meeting these pharmaceutical giants now could be considered as an advance publicity for their lung cancer drug. Then he could directly reject the acquisition when the time comes.

Moreover, if someone comes all the way here and you don't even meet them, you've already made an enemy invisibly.

Small businesses are fine and there is no need to worry.

But AbbVie is not a small company.

We don’t have to consider them domestically, but what about the foreign market in the future?

……

"Have you heard? Qin Guoming acquired Chen Xuan's formula."

"What? Qin Guoming has already acquired Chen Xuan's new drug formula? When did this happen?"

"Don't talk nonsense. Chen Xuan himself doesn't know about this. It's just that Changfeng Group wants to acquire the formula, hasn't it already acquired it?"

"I also heard that Changfeng Group offered 100 billion yuan to obtain the exclusive patent for the new drug formula."

"100 billion? Holy shit! Another 100 billion. Is Chen Xuan really going to have more money than he can spend? He won't agree to that, will he?"

"How much do you despise this lung cancer drug? Chen Xuan's previous formula sold for over 100 billion yuan. This new formula must be priced higher."

"After Qin Guoming's 100 billion acquisition failed, he planned to use 120 billion to acquire 60% of Antai Pharmaceutical Group's shares, but was also rejected."

"Six, he wants to acquire 60% of Antai Pharmaceutical Group's shares for 120 billion yuan. How did he start exporting?"

Just as Chen Xuan and Luo Shiyun thought,

After the news was released, it instantly became popular on the entire Internet.

This is also because the clinical trials of the lung cancer drug are so popular, and now that news of an acquisition has suddenly emerged, the heat will naturally explode.

However, everyone felt that the price of 100 billion yuan was too low and did not match the total value of the lung cancer drug.

Most drug formulas are certainly not worth 100 billion.

But the lung cancer specific drug is different. It is the only specific drug that can treat late-stage lung cancer and can also treat multiple indications.

The market value of lung cancer-specific drugs is certainly far more than 100 billion yuan.

Therefore, many netizens were very contemptuous of the fact that Changfeng Group only offered 100 billion yuan.

As for Qin Guoming's desire to acquire 60% of Antai Pharmaceutical Group's shares by spending 120 billion yuan, this made everyone think he was daydreaming.

Antai Pharmaceutical Group owns the formula and a large amount of fixed assets. With the presence of Chen Xuan, even ordinary people know that its valuation will not be less than 300 billion.

It is indeed a bit outrageous to want to acquire 60% of the shares with 120 billion yuan.

However, the news of Changfeng Group's acquisition of Antai Pharmaceutical Group still made many people nervous.

After all, most people are more familiar with Changfeng Group, which is an out-and-out business group that is truly profit-oriented.

The specific medicine for lung cancer may become a sky-high priced drug in Chen Xuan's hands.

But this "天" is just an adjective.

But if it falls into the hands of Changfeng Group, then this "sky" will be a real sky.

Because of this, most ordinary people do not want Antai Pharmaceutical Group to be acquired by Changfeng Group. This is something that no one wants to see.

The news that Qin Guoming had been rejected by Chen Xuan also made countless people cheer.

At the same time, they also felt that Qin Guoming and Changfeng Group were too short-sighted. They wanted to acquire Antai Pharmaceutical Group for 120 billion yuan, which was simply underestimating Chen Xuan's value.

……

"Someone must have arranged this on purpose."

"Antai Pharmaceutical Group deliberately spread this news and wanted everyone to know."

"This way of doing things shouldn't come from Chen Xuan, but from Luo Shiyun. It seems I underestimated that woman's methods."

In the presidential suite of a five-star hotel, Qin Guoming put down the book in his hand with a somewhat ugly expression.

This sudden news made it impossible for him to concentrate on reading.

He didn't expect that the news of his meeting with Chen Xuan would spread so quickly, especially the acquisition price was exposed.

This is not good news for him. If his bottom price is exposed, it will only allow his competitors to seize this opportunity, which will put him in a passive position.

Qin Guoming also immediately thought that someone had spread the news deliberately. This could not have been an accidental leak, it could only have been intentional.

As for why we do this,

It's nothing more than wanting to give Changfeng Group a warning.

Or they want to spread the price so that other competitors can negotiate with higher bids.

Qin Guoming believes that such a style should come from Luo Shiyun.

As for why it wasn't Chen Xuan, he felt that the latter's personality wouldn't allow him to do that. A person immersed in drug experiments wouldn't think about so many commercial means.

It’s not about whether this person has the ability to do it, but that he simply doesn’t bother to do so.

Therefore, he immediately thought of Luo Shiyun.

He knew the latter and once wanted to recruit him to help him.

But after getting to know her, I realized that Luo Shiyun's personality was too distinct and might be inconsistent with the group's values, so I gave up the idea.

But he also had to admit that Luo Shiyun's business methods and vision were excellent, and now he had witnessed it firsthand.

In just one night, he was in a passive state.

This is a bad influence for Changfeng Group. I don’t know how many netizens will give it a negative image.

……